Radretumab

Radretumab
481€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Radretumab
Category
Biosimilars
Provider
Abbexa
Reference
abx831217
Tested Applications
ELISA, WB

Description

Radretumab is a fully Human monoclonal antibody biosimilar expressed in CHO cells, targeting FN EDB, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Biosimilars
Immunogen Target
Target: FN EDB
Host
Human
Reactivity
Human
Assay Data
Concentration: Batch-dependent, typically between 0.5-2.0 mg/ml.
Tag: [(scFv-heavy Kappa)-IGHE-CH4]2
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Expression
Recombinant
Purity
> 95%
Purification
Purified from cell culture supernatants by Protein A/G chromatography.
Size 1
100 µg
Size 2
1 mg
Form
Liquid
Tested Applications
ELISA, WB
Buffer
0.01 M PBS. pH 7.4.
Availability
Shipped within 7-12 working days.
Storage
Store at 4°C for up to 2 weeks. Aliquot and store at -20°C for long term storage. Avoid repeated freeze/thaw cycles.
Shelf Life: 12 months.
Dry Ice
No
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
CAS Number: 1253180-81-2